(Q38079186)

28 August 2017

1 reference

title

Whither pathogenetic treatments for diabetic polyneuropathy? (English)

1 reference

28 August 2017

0 references

1

Andrew J M Boulton

1 reference

28 August 2017

Peter Kempler

2

1 reference

PubMed ID

23381942

28 August 2017

Alexander Ametov

series ordinal

3

1 reference

PubMed ID

23381942

28 August 2017

Dan Ziegler

series ordinal

4

1 reference

28 August 2017

1 July 2013

1 reference

Diabetes - Metabolism: Research and Reviews

28 August 2017

1 reference

28 August 2017

29

1 reference

28 August 2017

5

1 reference

28 August 2017

327-333

1 reference

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

28 August 2017

1 reference

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS).

21 January 2018

1 reference

Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.

21 January 2018

1 reference

Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial

21 January 2018

1 reference

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments

21 January 2018

1 reference

New diagnostic tests for diabetic distal symmetric polyneuropathy

21 January 2018

1 reference

Pathophysiology and treatment of painful diabetic neuropathy.

21 January 2018

1 reference

Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy

21 January 2018

1 reference

Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study.

21 January 2018

1 reference

The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study

21 January 2018

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

Enhanced glucose control for preventing and treating diabetic neuropathy

21 January 2018

1 reference

Efficacy and safety of lacosamide in painful diabetic neuropathy

21 January 2018

1 reference

Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study

21 January 2018

1 reference

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

Systematic review of topical capsaicin for the treatment of chronic pain

21 January 2018

1 reference

Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia

21 January 2018

1 reference

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

21 January 2018

1 reference

Current concepts in the management of diabetic polyneuropathy

21 January 2018

1 reference

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

21 January 2018

1 reference

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

21 January 2018

1 reference

Ranirestat for the management of diabetic sensorimotor polyneuropathy

21 January 2018

1 reference

Diabetic neuropathy: cellular mechanisms as therapeutic targets

21 January 2018

1 reference

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

21 January 2018

1 reference

Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

21 January 2018

1 reference

Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial

21 January 2018

1 reference

Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action

21 January 2018

1 reference

Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients

21 January 2018

1 reference

Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality

21 January 2018

1 reference

Efficacy by ulcer type and safety of lipo-PGE1 for Japanese patients with diabetic foot ulcers

21 January 2018

1 reference

Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study

21 January 2018

1 reference

The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes

21 January 2018

1 reference

Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus

21 January 2018

1 reference

Whither clinical research in diabetic sensorimotor peripheral neuropathy? Problems of end point selection for clinical trials

21 January 2018

1 reference

7 January 2021

Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity

1 reference

7 January 2021

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial

1 reference

7 January 2021

Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).

1 reference

7 January 2021

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.2397

1 reference

28 August 2017

1 reference

PubMed ID

23381942